This episode is part of Financial Forensics Labs — two shows, one forensic methodology: The Due Diligence Files traces how institutions collapse, The Signal Files traces how the good calls get made. Built from primary-record research by a 15-year capital markets professional.
Get to know the framework, the other show, and the tools built from it — all in one place.
Explore
Financial Forensics Labs — Forensic Finance Intelligence
In September 2019, Purdue Pharma filed for Chapter 11 bankruptcy under the weight of thousands of state, municipal, and individual claims stemming from the nationwide opioid crisis. However, internal balance sheet records show that the company's ultimate financial restructuring began more than a decade prior. Following Purdue’s 2007 federal guilty plea for misbranding OxyContin, ownership dramatically shifted its annual revenue distribution ratio from under 15% to as high as 70%. Between 2008 and 2016, the Sackler family extracted approximately $11 billion from the enterprise, draining roughly three-quarters of its total asset base before the mass tort liabilities could fully crystallize in court.
The extracted capital was systematically routed through a web of offshore holding companies, Jersey-based trusts, and Swiss bank accounts, creating a jurisdictional shield designed to complicate future creditor attachment. When Purdue eventually entered bankruptcy court, the controlling family attempted to secure absolute civil immunity through non-consensual third-party releases without ever placing their personal fortunes into federal bankruptcy jurisdiction. Under the initial 2021 reorganization plan, the family proposed contributing $4.5 billion back into the estate over nine years in exchange for a full legal release binding on all claimants, including thousands of victims who explicitly voted against the deal.
On June 27, 2024, the United States Supreme Court struck down the proposed architecture in a historic 5-to-4 ruling, establishing that bankruptcy courts lack statutory authority to extinguish claims against non-debtors without explicit claimant consent. This decision forced a revised 2025 settlement framework where family contributions rose to between $6.5 and $7.0 billion—a nearly 60% increase—bound strictly to consenting parties. This financial autopsy dissects the mechanics of pre-bankruptcy asset extraction, offshore wealth preservation, and the collapse of non-debtor release mechanisms in modern corporate restructurings. The Signal Files — Every advantage leaves behind a signal. We trace it.
